Mutations

PSEN1 L174del

Overview

Pathogenicity: Alzheimer's Disease : Pathogenic
Clinical Phenotype: Alzheimer's Disease
Reference Assembly: GRCh37 (105)
Position: Chr14:73653600 CTG>---
dbSNP ID: NA
Coding/Non-Coding: Coding
Mutation Type: Deletion
Codon Change: CTG to ---
Reference Isoform: PSEN1 isoform 1 (467 aa)
Genomic Region: Exon 6

Findings

The index patient, a 50-year-old male, suffered from progressive memory loss and depression (Tiedt et al., 2013). At age 53, he was diagnosed with early AD based on neuropsychological tests, neuroimaging, and analysis of cerebrospinal fluid (CSF) markers. The patient’s father and paternal grandmother also experienced memory loss and cognitive decline.

Neuropathology
Although neuropathology data are unavailable for this mutation, an MRI brain scan of the proband revealed slight temporal lobe atrophy.

Biological Effect
Measurements of AD biomarkers in the cerebrospinal fluid of the proband revealed increased levels of Aβ40, and reduced levels of Aβ42, resulting in a decreased Aβ42/Aβ40 ratio. A cryo-electron microscopy study of the atomic structure of γ-secretase bound to an APP fragment suggests mutations in L174 could alter the protein's local conformation and affect the positioning of residues that directly contribute to substrate binding (Zhou et al., 2019; Jan 2019 news).

Last Updated: 14 Aug 2019

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

News Citations

  1. CryoEM γ-Secretase Structures Nail APP, Notch Binding

Paper Citations

  1. . Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer's disease. Neurosci Lett. 2013 Jun 7;544:115-8. PubMed.
  2. . Recognition of the amyloid precursor protein by human γ-secretase. Science. 2019 Feb 15;363(6428) Epub 2019 Jan 10 PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . Previously not recognized deletion in presenilin-1 (p.Leu174del.) in a patient with early-onset familial Alzheimer's disease. Neurosci Lett. 2013 Jun 7;544:115-8. PubMed.

Other mutations at this position

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.